These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14141801)

  • 21. [Place of electromyography of the urethral striated sphincter in explorations of the urinary tract].
    Bollack C; Isch F; Jesel M; Rieffel R; Masson JC; Fresnel PL; Pietri J
    J Urol Nephrol (Paris); 1969 Jun; 75(6):413-39. PubMed ID: 4186639
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of a 6FG urethral catheter on urinary flow in benign prostatic hypertrophy.
    Anikwe RM
    Int Surg; 1976 Aug; 61(8):417-8. PubMed ID: 61185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benign prostatic hypertrophy and lower urinary obstruction.
    ARDUINO LJ
    J Lancet; 1963 Jun; 83():227-31. PubMed ID: 14013667
    [No Abstract]   [Full Text] [Related]  

  • 24. Urinary flow rate in benign prostatic hypertrophy.
    Anikwe RM
    Int Surg; 1976 Feb; 61(2):109-11. PubMed ID: 56317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [IMPORTANCE OF TRANSURETHRAL RESECTION (TUR) OR RESECTOSCOPY IN UROLOGY].
    COSTA J
    J Med (Oporto); 1964 Jun; 54():441-50. PubMed ID: 14161644
    [No Abstract]   [Full Text] [Related]  

  • 26. Prostatic enlargement.
    Blandy J
    Practitioner; 1989 Apr; 233(1466):512-7. PubMed ID: 2481304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NODULAR HYPERPLASIA OF THE PROSTATE IN NORTH INDIA: AN AUTOPSY STUDY.
    AHLUWALIA MS; TANDON HD
    J Urol; 1965 Jan; 93():94-101. PubMed ID: 14257055
    [No Abstract]   [Full Text] [Related]  

  • 29. [ON THE ROLE OF URINARY STASIS IN THE PATHOGENESIS OF CANCER OF THE URINARY BLADDER].
    PERELMAN VM; SHABAD AL
    Vopr Onkol; 1963; 9():82-7. PubMed ID: 14139242
    [No Abstract]   [Full Text] [Related]  

  • 30. The diagnosis of lower urinary tract obstruction.
    BERMAN HI
    J Lancet; 1963 Jun; 83():219-26. PubMed ID: 13970917
    [No Abstract]   [Full Text] [Related]  

  • 31. THE HYDRODYNAMICS OF MICTURITION. EXAMINATION BY MEANS OF MICRO-MANOMETER AND UROFLOWMETER OF THE HYDRODYNAMIC CONDITIONS IN NORMAL SUBJECTS AND IN PATIENTS SUFFERING FROM OBSTRUCTION IN THE POSTERIOR PART OF THE URETHRA.
    HOLM HH
    Acta Radiol Diagn (Stockh); 1964; ():SUPPL 231:1+. PubMed ID: 14277174
    [No Abstract]   [Full Text] [Related]  

  • 32. [The urinary tract of paraplegics; your care].
    SANCHEZ SANUDO L
    Dia Med; 1947 Jun; 19(30):985-8. PubMed ID: 18895945
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the treatment of acute urinary retention in patients with prostatic disorders].
    HEUSSER H
    Schweiz Med Wochenschr; 1963 Feb; 93():200-1. PubMed ID: 13954274
    [No Abstract]   [Full Text] [Related]  

  • 34. Convective Water Vapor Energy for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia.
    DeLay KJ; McVary KT
    Urol Clin North Am; 2016 Aug; 43(3):371-5. PubMed ID: 27476129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between lower urinary tract symptoms and urethral function in benign prostatic hyperplasia.
    Kaplan SA
    J Urol; 2005 Sep; 174(3):1010-1. PubMed ID: 16094029
    [No Abstract]   [Full Text] [Related]  

  • 36. [New ways in the medical treatment of prostatic hypertrophy and of urinary incontinence].
    RIEBEN W; CIEPIELOWSKI J; BAUMANN W; OTT W
    Urol Int; 1955; 1(6):440-7. PubMed ID: 13312173
    [No Abstract]   [Full Text] [Related]  

  • 37. Diabetes and benign prostatic hyperplasia/lower urinary tract symptoms--what do we know?
    Sarma AV; Parsons JK; McVary K; Wei JT
    J Urol; 2009 Dec; 182(6 Suppl):S32-7. PubMed ID: 19846144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiology and differential diagnosis of benign prostatic hypertrophy.
    Blaivas JG
    Urology; 1988 Dec; 32(6 Suppl):5-11. PubMed ID: 2462303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study.
    Roehrborn CG; Siami P; Barkin J; Damião R; Major-Walker K; Morrill B; Montorsi F;
    J Urol; 2008 Feb; 179(2):616-21; discussion 621. PubMed ID: 18082216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased urinary nerve growth factor reflects prostatic volume reduction and relief of outlet obstruction in patients with benign prostatic enlargement treated with dutasteride.
    Wada N; Matsumoto S; Kita M; Hashizume K; Kakizaki H
    Int J Urol; 2014 Dec; 21(12):1258-62. PubMed ID: 25039474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.